KZA
Click for more information
0.00% 8.0¢ kazia therapeutics limited

phase ii : are the results good enough to pass?

  1. mkhc
    57 Posts.
    clock Created with Sketch.
    12/09/03
    11:31
    Post #: 246443
    Is 20-30 % response rate for the ovarian cancer trials in Yale good enough to proceed to Phase III?

    Surely this would be be their major short medium term hurdle.

    Interested in your opinions on this.

    I hold NRT
    NRT Price at posting: 0.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply
 

Featured News

CC9 Chariot ends quarter charged up on lithium find in Wyoming
right-arrow Created with Sketch.
RCE Recce wins safety board approval to dose 4g in R327 UTI infusion trial
right-arrow Created with Sketch.
RDN Raiden's key target areas found drill ready in cultural heritage survey
right-arrow Created with Sketch.
NEWS Recharged Prospects: ‘Watts’ on the horizon for copper & lithium
right-arrow Created with Sketch.
BHP BHP confirms £31.1B takeover bid for Anglo American
right-arrow Created with Sketch.
ASM Aust Strategic sees Canada join US in possible funding push for Dubbo
right-arrow Created with Sketch.

Top Stories

watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.